H. Bouman

发表

Allelic Landscape of Human Blood Cell Trait Variation and Links

William J. Astle, James R. Staley, J. Danesh, 2016 .

Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation.

V. Deneer, J. T. ten Berg, B. Rensing, 2010, JAMA.

High on-treatment platelet reactivity to both aspirin and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention

J. T. ten Berg, J. Kelder, H. Bouman, 2011, Heart.

Determinants of agreement between proposed therapeutic windows of platelet function tests in vulnerable patients

H. ten Cate, A. T. ten Cate‐Hoek, Y. Henskens, 2017, European heart journal. Cardiovascular pharmacotherapy.

Effect of gender difference on platelet reactivity

F. Zijlstra, M. Sluman, J. M. Berg, 2011, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

The influence of CYP2C19*2 and *17 on on-treatment platelet reactivity and bleeding events in patients undergoing elective coronary stenting

A. de Boer, O. Klungel, V. Deneer, 2012, Pharmacogenetics and genomics.

The impact of renal function on platelet reactivity and clinical outcome in patients undergoing percutaneous coronary intervention with stenting

W. Bos, T. Bergmeijer, J. T. ten Berg, 2014, Thrombosis and Haemostasis.

Combined influence of proton‐pump inhibitors, calcium‐channel blockers and CYP2C19*2 on on‐treatment platelet reactivity and on the occurrence of atherothrombotic events after percutaneous coronary intervention

P. Souverein, A. de Boer, V. Deneer, 2011, Journal of thrombosis and haemostasis : JTH.

The relevance of P2Y12-receptor gene variation for the outcome of clopidogrel-treated patients undergoing elective coronary stent implantation: A clinical follow-up

J. T. ten Berg, H. ten Cate, F. Leebeek, 2011, Thrombosis and Haemostasis.

Which platelet function test is suitable to monitor clopidogrel responsiveness? A pharmacokinetic analysis on the active metabolite of clopidogrel

J. T. ten Berg, H. ten Cate, H. Bouman, 2010, Journal of thrombosis and haemostasis : JTH.

The relationship between platelet reactivity and infarct-related artery patency in patients presenting with a ST-elevation myocardial infarction

J. T. ten Berg, J. Kelder, H. Bouman, 2011, Thrombosis and Haemostasis.

Reply to: "Paraoxonase-1 and clopidogrel efficacy"

C. Hirschhäuser, E. Schömig, H. Bouman, 2011, Nature Medicine.

Platelet function tests for the monitoring of P2Y12 inhibitors.

J. T. ten Berg, H. Bouman, N. Breet, 2010, Expert opinion on medical diagnostics.

The use of the VerifyNow system to monitor antiplatelet therapy: A review of the current evidence

J. T. ten Berg, H. Bouman, J. V. van Werkum, 2008, Platelets.

Is platelet inhibition due to thienopyridines increased in elderly patients, in patients with previous stroke and patients with low body weight as a possible explanation of an increased bleeding risk?

F. Zijlstra, J. M. Berg, J. T. ten Berg, 2011, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Both peak and late aggregation are capable of identifying patients at risk for atherothrombotic events

J. T. ten Berg, J. Kelder, H. Bouman, 2010, Thrombosis and Haemostasis.

High on‐aspirin platelet reactivity as measured with aggregation‐based, cyclooxygenase‐1 inhibition sensitive platelet function tests is associated with the occurrence of atherothrombotic events

J. T. ten Berg, J. Kelder, H. Bouman, 2010, Journal of thrombosis and haemostasis : JTH.

The Cone-and-Plate(let) analyzer is not suitable to monitor clopidogrel therapy: a comparison with the flowcytometric VASP assay and optical aggregometry.

J. T. ten Berg, H. Bouman, N. Breet, 2010, Thrombosis research.

A comparison between the Plateletworks-assay and light transmittance aggregometry for monitoring the inhibitory effects of clopidogrel.

J. T. ten Berg, H. Bouman, J. V. van Werkum, 2010, International journal of cardiology.

A case–control study on platelet reactivity in patients with coronary stent thrombosis

J. T. ten Berg, H. ten Cate, H. Bouman, 2011, Journal of thrombosis and haemostasis : JTH.

Besides CYP2C19*2, the variant allele CYP2C9*3 is associated with higher on-clopidogrel platelet reactivity in patients on dual antiplatelet therapy undergoing elective coronary stent implantation

A. de Boer, O. Klungel, V. Deneer, 2010, Pharmacogenetics and genomics.

Do not adjust the platelet count in light transmittance aggregometry when predicting thrombotic events after percutaneous coronary intervention

J. T. ten Berg, J. Kelder, H. Bouman, 2010, Journal of thrombosis and haemostasis : JTH.

Comparison between hirudin and citrate in monitoring the inhibitory effects of P2Y12 receptor antagonists with different platelet function tests

J. T. ten Berg, H. Bouman, J. V. van Werkum, 2009, Journal of thrombosis and haemostasis : JTH.

The influence of clinical characteristics, laboratory and inflammatory markers on ‘high on-treatment platelet reactivity’ as measured with different platelet function tests

F. Verheugt, J. T. ten Berg, H. Bouman, 2009, Thrombosis and Haemostasis.

Cangrelor increases the magnitude of platelet inhibition and reduces interindividual variability in clopidogrel-pretreated subjects

N. Clappers, H. Bouman, C. Hackeng, 2009, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

The importance of anticoagulant agents in measuring platelet aggregation in patients treated with clopidogrel and aspirin

F. Verheugt, J. T. ten Berg, H. Bouman, 2008, Journal of thrombosis and haemostasis : JTH.

Variability in on-treatment platelet reactivity explained by CYP2C19*2 genotype is modest in clopidogrel pretreated patients undergoing coronary stenting

T. Bergmeijer, V. Deneer, J. T. ten Berg, 2011, Heart.

Uganda Genome Resource Enables Insights into Population History and Genomic Discovery in Africa

Mary D. Fortune, D. Heckerman, A. Reiner, 2019, Cell.

Platelet function is modified by common sequence variation in megakaryocyte super enhancers

William J. Astle, Jonathan M. Cairns, Benjamin B. Sun, 2017, Nature Communications.

Paraoxonase-1 is a major determinant of clopidogrel efficacy

C. Hirschhäuser, E. Schömig, H. Bouman, 2011, Nature Medicine.

CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control study.

A. de Boer, O. Klungel, V. Deneer, 2010, European heart journal.

Common Variation in the Platelet Receptor P2RY12 Gene Is Associated With Residual On-Clopidogrel Platelet Reactivity in Patients Undergoing Elective Percutaneous Coronary Interventions

F. Leebeek, M. D. de Maat, A. Kruit, 2009, Circulation. Cardiovascular genetics.

Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis

J. T. ten Berg, H. Bouman, N. Ford, 2011, BMJ : British Medical Journal.

Evaluating the diagnostic accuracy of maximal aortic diameter, length and volume for prediction of aortic dissection

E. Natour, J. Maessen, H. Crijns, 2020, Heart.

The influence of variation in the P2Y12 receptor gene on in vitro platelet inhibition with the direct P2Y12 antagonist cangrelor

J. T. ten Berg, F. Leebeek, A. Kruit, 2009, Thrombosis and Haemostasis.

A Scalable Synthesis of (±)-2-Oxoclopidogrel

C. Hirschhäuser, H. Bouman, H. Schmalz, 2010 .

Satellite

H. Bouman, N. Breet, J. W. Werkum, 2010, Pathophysiology of Haemostasis and Thrombosis.

Besides CYP2C19*2, the variant allele CYP2C9*3 is associated with higher on-clopidogrel platelet reactivity in patients on dual antiplatelet therapy undergoing elective coronary stent implantation

A. de Boer, O. Klungel, V. Deneer, 2010, Pharmacogenetics and genomics.

Cytochrome P-450 polymorphisms and response to clopidogrel.

H. Bouman, J. V. van Werkum, D. Taubert, 2009, The New England journal of medicine.

Do not adjust the platelet count in light transmittance aggregometry when predicting thrombotic events after percutaneous coronary intervention

H. Bouman, N. Breet, C. Hackeng, 2010, Journal of Thrombosis and Haemostasis.

The influence of clinical characteristics, laboratory and inflammatory markers on ‘high on-treatment platelet reactivity’ as measured with different platelet function tests

F. Verheugt, J. T. ten Berg, H. Bouman, 2009, Thrombosis and Haemostasis.

CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control study.

A. de Boer, O. Klungel, V. Deneer, 2010, European heart journal.

Common variation in the platelet receptor P2RY12 gene is associated with

A. Kruit, H. Bouman, C. Hackeng, 2009 .

The importance of anticoagulant agents in measuring platelet aggregation in patients treated with clopidogrel and aspirin

H. Bouman, C. Hackeng, J. W. Werkum, 2008, Journal of thrombosis and haemostasis : JTH.